Amylyx Pharmaceuticals In... (AMLX)
NASDAQ: AMLX
· Real-Time Price · USD
4.79
0.27 (5.97%)
At close: May 16, 2025, 3:59 PM
4.77
-0.52%
After-hours: May 16, 2025, 06:51 PM EDT
5.97% (1D)
| Bid | 3.97 |
| Market Cap | 427.43M |
| Revenue (ttm) | -1.27M |
| Net Income (ttm) | -218.86M |
| EPS (ttm) | -3.1 |
| PE Ratio (ttm) | -1.55 |
| Forward PE | -2.4 |
| Analyst | Buy |
| Ask | 5 |
| Volume | 643,633 |
| Avg. Volume (20D) | 862,187 |
| Open | 4.54 |
| Previous Close | 4.52 |
| Day's Range | 4.45 - 4.82 |
| 52-Week Range | 1.57 - 7.27 |
| Beta | -0.59 |
About AMLX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AMLX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AMLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+4.73%
Amylyx Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
6 months ago
+11.34%
Amylyx Pharmaceuticals shares are trading higher after Baird upgraded the stock from Neutral to Outperform and raised its price target from $3 to $11.
